Omega Fund Management, LLC Cidara Therapeutics, Inc. Transaction History

Omega Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.18 - $2.18 $2.37 Million - $4.37 Million	-2,005,249 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$2.39 - $4.0 $6,933 - $11,604	-2,901 Reduced 0.14%	2,005,249 $7.4 Million
Q1 2020 May 14, 2020	BUY	$1.74 - $4.26 $639,686 - $1.57 Million	367,636 Added 22.41%	2,008,150 $4.98 Million
Q3 2019 Nov 13, 2019	BUY	$1.25 - $2.35 $164,650 - $309,542	131,720 Added 8.73%	1,640,514 $3.27 Million
Q2 2018 Aug 02, 2018	BUY	$3.75 - $6.05 $3.99 Million - $6.44 Million	1,063,829 Added 239.08%	1,508,794 $7.85 Million

Q3 2017 Nov 03, 2017	BUY	$5.75 - $8.1 $2.56 Million - $3.6 Million	444,965	444,965 $3.6 Million

22.1M

2.7K

100

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $889M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Omega Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Omega Fund Management, LLC with notifications on news.